BSE Live
Jan 19, 10:29Prev. Close
534.65
Open Price
534.15
Bid Price (Qty.)
528.10 (17)
Offer Price (Qty.)
529.90 (36)
NSE Live
Jan 19, 10:29Prev. Close
534.75
Open Price
533.00
Bid Price (Qty.)
528.05 (15)
Offer Price (Qty.)
528.60 (18)
| Cash Flow of Rossari Biotech (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 4.70 | 4.19 | 5.75 | 6.15 | 5.75 | |
| Net CashFlow From Operating Activities | 0.01 | 6.24 | 2.28 | 1.94 | 2.28 | |
| Net Cash Used In Investing Activities | -2.13 | 3.53 | 6.17 | 5.24 | -6.17 | |
| Net Cash Used From Financing Activities | 2.75 | 2.89 | -3.89 | -3.18 | -3.89 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.62 | 12.66 | 4.56 | 4.00 | -7.77 | |
| Cash And Cash Equivalents Begin of Year | 0.33 | 0.51 | 0.35 | 0.00 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 0.95 | 13.17 | 4.91 | 0.00 | 0.00 |
19.01.2026
24.10.2025
16.10.2025
Rossari Consolidated September 2025 Net Sales at Rs 586.11 crore, up 17.61% Y-o-Y
16.10.2025
Rossari Standalone September 2025 Net Sales at Rs 419.51 crore, up 24.86% Y-o-Y
16.10.2025
Rossari Consolidated September 2025 Net Sales at Rs 586.11 crore, up 17.61% Y-o-Y
16.10.2025
Rossari Standalone September 2025 Net Sales at Rs 419.51 crore, up 24.86% Y-o-Y
21.07.2025
Rossari Consolidated June 2025 Net Sales at Rs 543.72 crore, up 11.04% Y-o-Y
21.07.2025
Rossari Standalone June 2025 Net Sales at Rs 365.76 crore, up 21.63% Y-o-Y